Americans who turned to telehealth companies and compounding pharmacies for cheap versions of Eli Lilly & Co.’s weight-loss ...

Fourteen years ago, the older drug cousin of semaglutide (Ozempic and Wegovy) came onto the market. The drug, liraglutide, is ...

The San Francisco telehealth company had capitalized on the shortage by making copycat versions of popular brand-name GLP-1 ...

The shortage of Eli Lilly’s (LLY) blockbuster diabetes and weight loss drugs is officially over, according to the U.S. Food ...

The change will expand access to the diabetes and weight-loss drugs. But it will also complicate the future of compounded ...

Patents for a drug related to Ozempic have expired, so pharmaceutical companies are working to develop ‘generic’ versions.

The effectiveness can vary based on the individual response and adherence to treatment. Research indicates that GLP-1 ...

There are several Ozempic alternatives available today, like Rybelsus, Mounjaro, Wegovy and Zepbound. Other medications may ...

Paying $1,200 a month for the name-brand drug Zepbound wasn’t sustainable, and it was becoming impossible to find, she said. And she’s not alone. Readdy turned to online communities where ...

The Halifax Street site is also closer to AIDS Programs South ... Gilmer had the same reaction. Like many community advocates, he emphasized that finding a permanent shelter spot is urgent ...

Compounding pharmacies have used a legal provision that allows them to make knockoff versions of Lilly’s Zepbound and Mounjaro while they are in a shortage. While Lilly has raised questions ...

Bioage's experimental drug, azelaprag, is being developed to treat obesity, in combination with GLP-1 agonists such as Eli Lilly's Zepbound and Novo Nordisk's Wegovy. Some analysts estimate that ...